Awarded Grants for CISNET III

This page lists the CISNET III (2010-2015) grantees and affiliates.

On this page:

Breast Cancer Group

Principal Investigator:

Georgetown University
Co-Principal Investigators:

University of Wisconsin

University of Texas MD Anderson

Dana-Farber Cancer Institute

Erasmus University Medical Center

Stanford University

Colorectal Cancer Group

Principal Investigator:

Memorial Sloan-Kettering Cancer Center
Co-Principal Investigators:

Erasmus University Medical Center

University of Minnesota- School of Public Health

Group Health Research Institute

Esophageal Cancer Group

Principal Investigator:

Massachusetts General Hospital [Columbia University Irving Medical Center since August 2018]
Co-Principal Investigators:

Fred Hutchinson Cancer Research Center

University of Washington

Lung Cancer Group

Principal Investigator:

Massachusetts General Hospital Institute for Technology Assessment
Co-Principal Investigators:

Erasmus University Medical Center

Pacific Institute for Research and Evaluation

Stanford University

Fred Hutchinson Cancer Research Center

Yale School of Public Health through Pacific Institute for Research and Evaluation

Prostate Cancer Group

Principal Investigator:

Fred Hutchinson Cancer Research Center
Co-Principal Investigators:

Erasmus University Medical Center

University of Michigan

CISNET Affiliate Program

In the spirit of open collaboration, CISNET encourages the participation of modelers who are not currently funded through the CISNET mechanism. Investigators working on population modeling of cancer trends who wish to be associated with the CISNET group may apply for affiliate status. Applicants for affiliate status are required to submit a written statement summarizing their prior related work to the Coordinating Center PI from the appropriate cancer site. If collaboration is deemed to be mutually beneficial, the prospective Affiliate and the Coordinating Center PI will work together to write a Statement of Work describing the intended collaborations with the CISNET group. Unanimous approval by CISNET PIs for the relevant cancer site and one designated NCI staff member will be required for affiliate status to be granted. Affiliates attend meetings, share results, and participate in joint collaborations when applicable.